Fundraising Fox

Brad Morie

Investor

Senior Director, Biotechnologies at Research Corporation Technologies

Tucson

Find your path to Brad

531 people in our graph share verified history with Brad — schools, employers, funds. One of them is your warm intro.

Michael TaylorunlockedBrad: together at Pfizer (1996–1997)
×7Brad: together at UNC Kenan-Flagler Business School
Brad: together at Pfizer
×3Brad: together at Wake Forest University

About

Brad Morie oversees the licensing of RCT's biotechnology programs, including Pichia Classic, Pichia GlycoSwitch, ClearColi and other protein expression platforms. He previously held business development and licensing roles at Ajinomoto Bio-Pharma Services, Catalent, Lonza, BIOCRATES and Los Alamos National Laboratory.

Contact· self-published, not guessed

Invests in

Biotech

Experience

  1. Research Corporation Technologies, Inc.Sr. Directorcurrent2019 — presentTucson, Arizona Area
  2. Medigen, Inc.Member Board of Advisorscurrent2014 — presentFrederick, MD
  3. Ajinomoto Bio-Pharma ServicesSr. Director, Business Development & Licensing2017 — 2019New Market, MD
  4. Ajinomoto Bio-Pharma ServicesDirector, Business Development & Licensing2014 — 2017New Market, MD
  5. Catalent Pharma SolutionsAccount Director, Softgel Consumer Healthcare2013 — 2014New Market, MD
  6. LonzaDirector, Business Development & Licensing2010 — 2013Walkersville, MD
  7. BiocratesDirector of Business Development & Marketing2006 — 2010
  8. Los Alamos National LaboratoryBusiness Development Executive2003 — 2006
  9. Commerx, Inc.Supplier Management Specialist1999 — 2001
  10. Austrian-American Fulbright CommissionInstructor1997 — 1999
  11. PfizerLaboratory Assistant1996 — 1997

Skills & more

Strategy36Biotechnology49Business Development22Strategic Partnerships18Licensing12Intellectual Asset Management5Corporate Development6Start-ups28Entrepreneurship9Business Analysis5Lifesciences14Commercialization21
+10 moreMarket AnalysisPharmaceutical IndustryProduct ManagementMarket ResearchVenture CapitalBusiness PlanningR&DBiopharmaceuticalsTechnology TransferFDA

Languages English · German

  • CLP — Certified Licensing Professionals, Inc.

From Brad's professional profile.

Colleagues at Research Corporation Technologies

Avi Roop
Managing Director at Research Corporation Technologies
Chad W. Souvignier
Vice President at Research Corporation Technologies
Christopher P. Martin
President, Medical Devices and CFO at Research Corporation Technologies
Danielle Wilson
Director of Administration & Corporate Secretary at Research Corporation Technologies
David A. Wiersma
Senior Associate at Research Corporation Technologies
Jorge Figueroa
Systems Administrator at Research Corporation Technologies
Kathleen M. Hunter-Gregory
Controller at Research Corporation Technologies
Maggie Zhou
Associate Controller at Research Corporation Technologies

Frequently asked questions

Who is Brad Morie?
Brad Morie oversees the licensing of RCT's biotechnology programs, including Pichia Classic, Pichia GlycoSwitch, ClearColi and other protein expression platforms. He previously held business development and licensing roles at Ajinomoto Bio-Pharma Services, Catalent, Lonza, BIOCRATES and Los Alamos National Laboratory.
Where does Brad Morie work?
Brad Morie is Senior Director, Biotechnologies at Research Corporation Technologies.
What does Brad Morie invest in?
Brad Morie invests in Biotech.
Where did Brad Morie go to school?
Brad Morie studied at UNC Kenan-Flagler Business School (MBA, General Management / Entrepreneurship); University of St.Gallen; Dobyns-Bennett High School.

Same school

Also attended UNC Kenan-Flagler Business School197

Mathew KayeAccounting Manager at RevolutionFrancesco MoroPrincipal at Burda Principal InvestmentsAmol BhatHead of Investor Relations at Mucker CapitalJoe SantaBarbaraChief Financial Officer at .406 VenturesTony WellsVenture Partner at Copper Sky CapitalTroy ArnoldPartner, Echo Health Advisors at Echo Health Ventures

+ 191 more

Also attended University of St.Gallen399

Melissa DonohoeVice President at Notion CapitalMarjolaine CatilPrincipal at Newfund CapitalGülce KoçInvestment Manager at IdacapitalDominik MatykaInvestor at Cavalry VenturesChristian NagelInvestor at Earlybird Venture CapitalKarol CieslukAssociate at TCV

+ 393 more

Also attended Wake Forest University150

Daniel van der MerweSenior Director at JMI EquityNash Carey-EwendSenior Associate, Echo Health Advisors at Echo Health VenturesAndrew McGuirkVenture Fellow at Moneta VenturesEliza CushmanPartner at Congruent VenturesBrett BrohlManaging Partner at Bread And Butter Ventures, LlcJeff BaldwinPrincipal at TCV

+ 144 more

Shared employers

Also worked at Catalent Pharma Solutions10

Jay FraserInvestor at Side Door VenturesOtello StampacchiaManaging Director at Omega FundsPatrick StragierInvestment Manager at Meusinvest (Noshaq)Oly UgorjiAnalyst at Blueprint EquityRussell BeckermanFounder / EIR at 82VSPedro SantosPrincipal at Varsity Healthcare Partners

+ 4 more

Also worked at Biocrates1

Rumman SyedManaging Partner at ARAX Capital Partners GmbH

Also worked at Los Alamos National Laboratory47

Lucas HarringtonCo-founder and CSO at SciFoundersPaul ConleyChairman & CEO at GENERAL INCEPTIONPeter LeeManaging Partner at Baroda VenturesAlex LuceGeneral Partner at Creative VenturesAndy KonwinskiFounder and General Partner at Laude VenturesSheila BakerDirector of Grants at Missouri Technology Corporation

+ 41 more

Also worked at Pfizer288

Jigar RaythathaInvestor at Third Rock VenturesAbbie CelnikerInvestor at Third Rock VenturesErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesMichael TaylorOperating Partner at Mission Biocapital

+ 282 more